trending Market Intelligence /marketintelligence/en/news-insights/trending/hx-g-ecrxt_rcp_dwtb75g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Immune Therapeutics appoints board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Immune Therapeutics appoints board member

Immune Therapeutics Inc. appointed Jack Brewer as a board member.

Brewer is the CEO and founder of the Brewer Group Cos. He manages Brewer's private portfolio, which focuses on impact investing.

Immune Therapeutics said that Brewer has assisted in the company's expansion into international markets, such as Malawi and Haiti, and has recently started work to help the company expand registration into India.

Orlando, Fla.-based Immune Therapeutics develops immunotherapies for autoimmune and inflammatory diseases, cancer, HIV/AIDS and animal diseases.